Health Care & Life Sciences » Biotechnology | Biotage AB

Biotage AB | Income Statement

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
444,644.00
490,381.00
610,535.00
667,912.00
748,147.00
910,896
Cost of Goods Sold (COGS) incl. D&A
219,277.00
251,956.00
300,684.00
321,894.00
320,142.00
370,334
Gross Income
225,367.00
238,425.00
309,851.00
346,018.00
428,005.00
540,562
SG&A Expense
183,919.00
196,807.00
234,403.00
254,664.00
288,078.00
370,996
EBIT
41,058.00
41,618.00
76,186.00
91,359.00
139,927.00
169,566
Unusual Expense
2,747.00
-
3,741.00
-
6,215.00
5,700
Non Operating Income/Expense
1,399.00
13,446.00
3,841.00
193.00
9,714.00
14,108
Interest Expense
437.00
331.00
187.00
23.00
-
1,737
Pretax Income
40,369.00
54,861.00
76,190.00
91,246.00
136,838.00
176,867
Income Tax
1,023.00
3,749.00
2,935.00
395.00
2,487.00
8,662
Equity in Affiliates
-
-
-
1,155.00
578.00
578
Consolidated Net Income
41,392.00
51,112.00
73,255.00
92,796.00
138,747.00
167,627
Net Income
41,392.00
51,112.00
73,255.00
92,796.00
138,747.00
167,627
Net Income After Extraordinaries
41,392.00
51,112.00
73,255.00
92,796.00
138,747.00
167,627
Net Income Available to Common
41,392.00
51,112.00
73,255.00
92,796.00
138,747.00
167,627
EPS (Basic)
0.61
0.79
1.13
1.43
2.14
2.59
Basic Shares Outstanding
68,139.30
64,714.40
64,714.40
64,714.40
64,714.40
64,714.40
EPS (Diluted)
0.61
0.79
1.13
1.43
2.14
2.59
Diluted Shares Outstanding
68,139.30
64,714.40
64,714.40
64,714.40
64,714.40
64,714.40
EBITDA
68,627.00
73,481.00
112,934.00
135,195.00
172,491.00
190,451
Other Operating Expense
390.00
-
738.00
5.00
-
-
Non-Operating Interest Income
1,096.00
128.00
91.00
103.00
410.00
630

About Biotage AB

View Profile
Address
Vimpelgatan 5
Uppsala UP 753 18
Sweden
Employees -
Website http://www.biotage.com
Updated 07/08/2019
Biotage AB engages in the provision of separation and synthesis technology solutions. Its products include equipment for chromatography and purification, organic synthesis, analytical sample preparation, evaporation and concentration, peptide synthesis, and custom projects. The company was founded by Pal Nyrén, Carl Erik Mathias Uhlén, Mostafa Ronaghi, Bertil Pettersson, Neil Goldsmith and Björn Ekström in 1997 and is headquartered in Uppsala, Sweden.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.